DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Spectrum Pharmaceuticals
Spectrum Pharmaceuticals
Manufacturers and Wholesalers Street
Biocentury 8.15.16
2020-2021 Cancer Communications Committee Disclosures All Relationships Are Considered Compensated
Spectrum Pharmaceuticals Inc
Based on Our Discussion with Radford, Management Identified Our Peer Companies to Include the Following 19 Biotechnology and Pharmaceutical Companies for 2015
JMP Securities Healthcare Conference to Be Held in New York
Company Description
13-ICML Abbvie Acerta Pharma Amgen (Europe) Gmbh Bayer
IHE Ishares US Pharmaceuticals ETF Gray Swan Event Factor For
Rebateable Manufacturers
WCLC 2020 Faculty Chairs Disclosure Summary
The Bottom 99
Oncology Grand Rounds
Disclosure of Financial Relationships April 10-15 • May 17-21
Oncology Pharmaceutical
MANUFACTURERS with CMS AGREEMENTS AS of 5-14-21 Labeler Code Labeler Name Program End Date 00002 ELI LILLY and COMPANY 00003 E.R
2018 Medicines in Development for Cancer
Table of Contents
Top View
A First-In-Human Phase I Study of the OX40 Agonist GSK3174998 (GSK998) +/- Pembrolizumab in Patients (Pts) with Selected Advanced Solid Tumors (ENGAGE-1)
SPECTRUM PHARMACEUTICALS, INC. (Exact Name of Registrant As Specified in Its Charter) ______
Expert Connect All Relationships Are Considered Compensated
Faculty Disclosure
Mark H. Izraelewicz Partner
The ASCO Post Editor Conflict of Interest Disclosures
02/04/2016 Provider Subsystem Healthcare and Family Services Run Time: 20:10:22 Report Id 2794D051 Page: 01
2794D051numericlist May 2015.Xlsx
Medicaid System (Mmis) Illinois Department of Run Date: 02/10/2015 Provider Subsystem Healthcare and Family Services Run Time: 20:51:09 Report Id 2794D052 Page: 01
2020 Annual Meeting Scientific Program Committee All Relationships Are Considered Compensated
Spectrum Pharmaceuticals Appoints Lee F. Allen, M.D., Ph.D., Industry Veteran, As Chief Medical Officer
U.S. Pharmaceutical/Biotech Industry Update
COVID-19 and Cancer DISCLOSURE of FINANCIAL RELATIONSHIPS
Rebateable Manufacturers
Numeric Complete List of Pharmaceutical Labelers with Signed Rebate Agreements in Effect As of 10/01/2015
Company Description
Ligand's Partner Spectrum Pharmaceuticals Reports
The Bottom 99
Spectrum Pharmaceuticals Inc
2794D052alphalist May 2015.Xlsx
Rebateable Manufacturers
From the Children's Oncology Group Phase III Study AALL0433
2015 AB 128 Code of Conduct Compliant Companies
2004 Annual Report
05/13/2021 Provider Subsystem Healthcare and Family Services Run Time: 20:39:26 Report Id 2794D052 Page: 01
Printmgr File
2013 Proxy Statement
Table of Contents